Litcius/Paper detail

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

Maria Sofia Basile, Eugenio Cavalli, James A. McCubrey, Jorge Hernández‐Bello, José Francisco Muñóz-Valle, Paolo Fagone, Ferdinando Nicoletti

2021Drug Discovery Today115 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwayProtein kinase BSignal transductionBiologyCancer researchCell biologyMedicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapy
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19 | Litcius